Radionetics Oncology’s Post

The growth of the global radiopharmaceutical market is driving healthcare innovation and scientific advancements, leading to improved diagnostic and therapeutic solutions. This expansion is also expected to significantly increase market valuation, reflecting a broader adoption in medical practices. Innovation + Growth = nextgen medications which ultimately drive improved patient outcomes. The ultimate Win Win.

Have you seen our on demand webinars? In this Webinar we'll review what a digital therapeutic is, some recent high level evidence for the use of digital therapeutics in the oncology space, and real world barriers to implementation in this space. 🔗 https://bit.ly/3S5aJtX

Did your organization apply for the reopened Enhancing Oncology Model (EOM)? In a recent Canopy webinar, thought leaders from CMS and community oncology shared helpful insights and strategies for success in the EOM and other value-based programs. Catch the full discussion to learn more: https://lnkd.in/ekfjd6V4

Discover the latest in real world data and digital oncology in ESMO Real World Data and Digital Oncology. Read our groundbreaking article, 'Equitable access to oncology clinical trials: harnessing technology to reduce geographic disparities' http://spkl.io/6043fuqYW

Going to EHA 2024? Connect with us to learn more about our tailored reports from the leading source of European oncology data. https://ow.ly/rCCm30sCZRl #EHA2024 #OncologyData #RealWorldResearch

Download our latest insight brief with Gerhard du Toit, Global Oncology Head at IQVIA Biotech, and learn how global oncology trends are impacting clinical trial strategy in early phase oncology, platform design trials, and diversity planning. Download now. https://bit.ly/3XYAxv1 #oncology #clinicaltrials #earlyphaseoncology

Going to EHA 2024? Connect with us to learn more about our tailored reports from the leading source of European oncology data. https://ow.ly/CXtg30sCE8F #EHA2024 #OncologyData #RealWorldResearch

If you are a MEDITECH #Expanse healthcare organization that is considering implementing the Oncology (ONC) module, you owe it to yourself to read this article by Haffty Consulting's own Ann Walsh, a leading clinical consultant with years of ONC experience.

When developing potentially life-saving oncology therapies, time is of the essence. Check out this new white paper where our experts outline operational strategies that can accelerate timelines.

Discover why an agile approach is crucial to overcoming oncology trial challenges. Learn more in the e-Book - A best practice guide for laboratory services in oncology trials leveraging customization and flexibility: https://lnkd.in/e6UWwYss